Metabolic pharmacokinetics of isoflavones in the roots of Pueraria lobata in rats

Mid-Taiwan Journal of Medicine

Volumn 10, Issue 2, 2005, Pages 57-64

  Chiang, Hsiu Mei ^a,b   Yeh, Yi Rou ^a   Chao, Pei Dawn Lee ^a   Hsiu, Su Lan ^a   Hou, Yu Chi ^a   Chi, Ying Chang ^a   Wen, Kuo Ching ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b JEN TEH JUNIOR COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Daidzein; Daidzin; Isoflavone; Pharmacokinetics; Pueraria lobata; Puerarin

Indexed keywords

ASCORBIC ACID; BETA GLUCURONIDASE; DAIDZEIN; DAIDZIN; ISOFLAVONE DERIVATIVE; PLANT EXTRACT; PUERARIN; SULFATASE;

AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CHINESE MEDICINE; CONCENTRATION (PARAMETERS); DRUG BLOOD LEVEL; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; MALE; MATHEMATICAL MODEL; NONHUMAN; PLANT ROOT; PUERARIA; RAT; RAT STRAIN;

EID: 21644467385     PISSN: 10293507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Middleton E, Kandaswami C. The impact of plant flavonoids on mammalian biology: Implications for immunity, inflammation and cancer. In: Harborne JB, ed. The Flavonoids: Advances in Research Since 1986. London, UK: Chapman and Hall, 1993;619-52.
2. Hanasaki Y, Ogawa S, Fukui S. The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radic Biol Med 1994; 16:845-50.
3. Hope WC, Welton AF, Fielder-Nagy C, et al. In vitro inhibition of the biosynthesis of slow reacting substances of anaphylaxis (SRS-A) and lipoxygenase activity of quercetin. Biochem Pharmacol 1983;32: 367-71.
4. Li BQ, Fu T, Yan YD, et al. Inhibition of HIV infection by baicalin - a flavonoid compound purified from Chinese herbal medicine. Cell Mol Biol Res 1993;39: 119-24.
5. Galati EM, Monforte MT, Kirjavainen S, et al. Biological effects of hesperidin, a citrus flavonoid. (Note I): antiinflammatory and analgesic activity. Farmaco 1994;40:709-12.
6. Bors W, Heller W, Michel C, et al. Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol 1990;186:343-55.
7. Wolfe K, Wu X, Liu RH. Antioxidant activity of apple peels. J Agric Food Chem 2003;51:609-14.
8. Wang HK, Xia Y, Yang ZY, et al. Recent advances in the discovery and development of flavonoids and their analogues as antitumor and anti-HIV agents. [Review] Adv Exp Med Biol 1998;439:191-225.
9. Choo MK, Park EK, Yoon HK, et al. Antithrombotic and antiallergic activities of daidzein, a metabolite of puerarin and daidzin produced by human intestinal microflora. Biol Pharm Bull 2002;25:1328-32.
10. Doerge DR, Sheehan DM. Goitrogenic and estrogenic activity of soy isoflavones. [Review] Environ Health Perspect 2002;110(Suppl 3):349-53.
11. Xu X, Duncan AM, Merz BE, et al. Effect of soy isoflavone on estrogen and phytoestrogen metabolism in postmenopausal woman. Cancer Epidemiol Biomarkers Prev 1998;7:1101-8.
12. Potter SM, Baum JA, Teng H, et al. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998;68(6 Suppl):1375-9.
13. Uesugi T, Fukui Y, Yamori Y. Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: a four-week study. J Am Coll Nutr 2002;21:97-102.
14. Han R. Highlight on the studies of anticancer drugs derived from plants in China. Stem Cells 1994;12:53-63.
15. Messina MJ, Persky V, Setchell KD, et al. Soy intake and cancer risk: a review of the in vitro and in vivo data. [Review] Nutr Cancer 1994;21:113-31.
16. Chan HY, Leung LK. A potential protective mechanism of soya isoflavones against 7,12-dimethylbenz[a]anthracene tumour initiation. Br J Nutr 2003;90:457-65.
17. Farhan H, Wahala K, Cross HS. Genistein inhibits vitamin D hydroxylases CYP24 and CYP27B1 expression in prostate cells. J Steroid Biochem Mol Biol 2003;84:423-9.
18. Anderson JW, Major AW. Pulses and lipaemia, short- and long-term effect: potential in the prevention of cardiovascular disease. Br J Nutr 2002;88(Suppl 3): 263-71.
19. van der Schouw YT, de Kleijn MJ, Peeters PH, et al. Phyto-oestrogens and cardiovascular disease risk. [Review] Nutr Metab Cardiovasc Dis 2000;10:154-67.
20. Arora A, Nair MG, Strasburg GM. Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch Biochem Biophys 1998;356:133-41.
21. Guo Q, Rimbach G, Moini H, et al. ESR and cell culture studies on free radical-scavenging and antioxidant activities of isoflavonoids. Toxicology 2002;179:171-80.
22. Ruiz-Larrea MB, Mohan AR, Paganga G, et al. Antioxidant activity of phytoestrogenic isoflavones. Free Radic Res 1997;26:63-70.
23. Zhang R, Li Y, Wang W. Enhancement of immune function in mice fed high doses of soy daidzein. Nutr Cancer 1997;29:24-8.
24. Yue HW, Hu XQ. Pharmacologic value of radix Puerariae and puerarin on cardiovascular system. [Review] Zhongguo Zhong Xi Yi Jie He Za Zhi 1996; 16:382-4. (In Chinese; English abstract)
25. Lee JS, Mamo J, Ho N, et al. The effect of Puerariae radix on lipoprotein metabolism in liver and intestinal cells. BMC Complement Altern Med 2002;2:12.
26. Wang X, Wu J, Chiba H, et al. Puerariae radix prevents bone loss in ovariectomized mice. J Bone Miner Metab 2003;21:268-75.
27. Kim DH, Yu KU, Bae EA, et al. Metabolism of puerarin and daidzin by human intestinal bacteria and their relation to in vitro cytotoxicity. Bio Pharm Bull 1998;21:628-30.
28. Yang CY, Tsai SY, Chao PDL, et al. Determination of hesperetin and its conjugate metabolites in serum and urine. J Food Drug Anal 2002;10:143-8.
29. Yasuda T, Kano Y, Saito K, et al. Urinary and biliary metabolites of puerarin in rats. Biol Pharm Bull 1995; 18:300-3.
30. Prasain JK, Jones K, Brissie N, et al. Identification of puerarin and its metabolites in rats by liquid chromatography-tandem mass spectrometry. J Agric Food Chem 2004;52:3708-12.
31. Yasuda T, Kano Y, Saito K, et al. Urinary and biliary metabolites of daidzin and daidzein in rats. Biol Pharm Bull 1994;17:1369-74.
32. Setchell KD, Brown NM, Zimmer-Nechemias L, et al. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am J Clin Nutr 2002;76:447-53.
33. Mackey AD, Henderson GN, Gregory JF 3rd. Enzymatic hydrolysis of pyridoxine-5′-beta-D-glucoside is catalyzed by intestinal lactase-phlorizin hydrolase. J Biol Chem 2002;277:26858-64.
34. Day AJ, Gee JM, DuPont MS, et al. Absorption of quercetin-3-glucoside and quercetin-4′-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter. Biochem Pharmacol 2003;65:1199-206.
35. Wilkinson AP, Gee JM, Dupont MS, et al. Hydrolysis by lactase phlorizin hydrolase is the first step in the uptake of daidzein glucosides by rat small intestine in vitro. Xenobiotica 2003;33:255-64.
36. Piskula MK. Factors affecting flavonoids absorption. Biofactors 2000;12:175-80.